Medical Information Only: This medication is not sold on this site. The information provided is for reference purposes only. Please consult your local physician or pharmacist for treatment.

Chibroxin: Full Drug Profile

Medically reviewed by Dr. Otari Nergadze, Neurosurgeon | Updated: January 2026

Chibroxin - General Information

A synthetic fluoroquinolone (fluoroquinolones) with broad-spectrum antibacterial activity against most gram-negative and gram-positive bacteria. Chibroxin inhibits bacterial DNA gyrase.

 

Pharmacology of Chibroxin

Chibroxin is a quinolone/fluoroquinolone antibiotic. Chibroxin is bactericidal and its mode of action depends on blocking of bacterial DNA replication by binding itself to an enzyme called DNA gyrase, which allows the untwisting required to replicate one DNA double helix into two. Notably the drug has 100 times higher affinity for bacterial DNA gyrase than for mammalian.

 

Chibroxin for patients

 

Chibroxin Interactions

Elevated plasma levels of theophylline have been reported with concomitant quinolone use. There have been reports of theophylline-related side effects in patients on concomitant therapy with norfloxacin and theophylline. Therefore, monitoring of theophylline plasma levels should be considered and dosage of theophylline adjusted as required.
Elevated serum levels of cyclosporine have been reported with concomitant use of cyclosporine with norfloxacin. Therefore, cyclosporine serum levels should be monitored and appropriate cyclosporine dosage adjustments made when these drugs are used concomitantly.
Quinolones, including norfloxacin, may enhance the effects of oral anticoagulants, including warfarin or its derivatives or similar agents. When these products are administered concomitantly, prothrombin time or other suitable coagulation tests should be closely monitored.
The concomitant administration of quinolones including norfloxacin with glyburide (a sulfonylurea agent) has, on rare occasions, resulted in severe hypoglycemia. Therefore, monitoring of blood glucose is recommended when these agents are co-administered.
Diminished urinary excretion of norfloxacin has been reported during the concomitant administration of probenecid and norfloxacin.
The concomitant use of nitrofurantoin is not recommended since nitrofurantoin may antagonize the antibacterial effect of Norfloxacin in the urinary tract.
Multivitamins, or other products containing iron or zinc, antacids or sucralfate should not be administered concomitantly with, or within 2 hours of, the administration of norfloxacin, because they may interfere with absorption resulting in lower serum and urine levels of norfloxacin.
Videx (Didanosine) chewable/buffered tablets or the pediatric powder for oral solution should not be administered concomitantly with, or within 2 hours of, the administration of norfloxacin, because these products may interfere with absorption resulting in lower serum and urine levels of norfloxacin.
Some quinolones have also been shown to interfere with the metabolism of caffeine. This may lead to reduced clearance of caffeine and a prolongation of its plasma half-life.

 

Chibroxin Contraindications

Norfloxacin is contraindicated in persons with a history of hypersensitivity, tendinitis, or tendon rupture associated with the use of norfloxacin or any member of the quinolone group of antimicrobial agents.

 

Additional information about Chibroxin

Chibroxin Indication: For the treatment of urinary tract infection Mechanism Of Action: The bactericidal action of Chibroxin results from inhibition of the enzymes topoisomerase II (DNA gyrase) and topoisomerase IV, which are required for bacterial DNA replication, transcription, repair, and recombination. Chibroxin is a broad-spectrum antibiotic that is active against both gram-positive and gram-negative bacterias. The fluorine atom at the 6 position increases potency against gram-negative organisms, and the piperazine moiety at the 7 position is responsible for anti-pseudomonal activity Drug Interactions: Aluminium Formation of non-absorbable complexes Bismuth Formation of non-absorbable complexes Calcium Formation of non-absorbable complexes Magnesium oxide Formation of non-absorbable complexes Magnesium Formation of non-absorbable complexes Iron Formation of non-absorbable complexes Zinc Formation of non-absorbable complexes Sucralfate Formation of non-absorbable complexes Theophylline The quinolone increases the effect of theophylline Oxtriphylline The quinolone increases the effect of theophylline Aminophylline The quinolone increases the effect of theophylline Dyphylline The quinolone increases the effect of theophylline Anisindione The quinolone increases the anticoagulant effect Acenocoumarol The quinolone increases the anticoagulant effect Dicumarol The quinolone increases the anticoagulant effect Warfarin The quinolone increases the anticoagulant effect Caffeine The quinolone increases the effect and toxicity of caffeine Cyclosporine The quinolone increases the effect and toxicity of cyclosporine Clozapine Ciprofloxacin may increase clozapine serum levels Foscarnet Increased risk of convulsions Food Interactions: Not Available Generic Name: Norfloxacin Synonyms: Not Available Drug Category: Anti-Infectives; Enzyme Inhibitors; Quinolones Drug Type: Small Molecule; Approved Other Brand Names containing Norfloxacin: Chibroxin; Noroxin; Absorption: Rapid Toxicity (Overdose): Not Available Protein Binding: 10 and 15% (Serum protein binding) Biotransformation: Via liver and kidney Half Life: 3-4 hours Dosage Forms of Chibroxin: Tablet Oral Chemical IUPAC Name: 1-ethyl-6-fluoro-4-oxo-7-piperazin-1-ylquinoline-3-carboxylic acid Chemical Formula: C16H18FN3O3 Norfloxacin on Wikipedia: https://en.wikipedia.org/wiki/Norfloxacin Organisms Affected: Enteric bacteria and other eubacteria